4 unknown. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Unknown 4 |
Follow Dyspareunia: new trials by email Literature Review of Dyspareunia trials Research Report on Dyspareunia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study to Evaluate the Efficacy of Prasterone Treatment for Atrophy Vulvovaginal in Postmenopausal Women With Vulvar / Vestibular Pain Prasterone 6.5 MG, Placebo - Vulvovaginal Atrophy | Phase 3 | Unknown | Dr. Santiago Palacios | 50 | 2020-12-22 | 2021-06-02 |
| Examining Effects of Intrarosa in Women With Genitourinary Syndrome of Menopause/Vulvovaginal Atrophy Intrarosa, Placebos - Menopause, Genitourinary Syndrome of Menopause | Phase 3 | Unknown | Center for Vulvovaginal Disorders | 40 | 2019-03-02 | 2019-01-31 |
| Botulinum Toxin Injection for Treatment of Vaginismus botulinum toxin, botulinum toxin A - Vaginismus | Phase 3 | Unknown | Tehran University of Medical Sciences | 40 | 2007-10-01 | 2008-03-18 |
| Treatment of Endometriosis With Norethindrone Acetate ( NA) VS. Gonadotropin- Releasing Hormone (GnRH) Agonist (Lupron Depot 11.25 mg) Norethindrone Acetate (NA), GnRH Agonist (Lupron Depot) - Endometriosis, Dysmenorrhea | Phase 3 | Unknown | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 112 | 2004-08-01 | 2012-10-25 |
Dysmenorrhea (1) · Endometriosis (1) · Pelvic Pain (1) · Vaginismus (1)
Female Urogenital Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4) · Genital Diseases (4) · Genital Diseases, Female (4) · Genital Diseases, Male (4) · Male Urogenital Diseases (4) · Mental Disorders (4) · Sexual Dysfunction, Physiological (4) · Sexual Dysfunctions, Psychological (4) · Urogenital Diseases (4) · Menstruation Disturbances (1) · Neurologic Manifestations (1) · Pain (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Dehydroepiandrosterone (2) · Botulinum Toxins (1) · Botulinum Toxins, Type A (1) · Control Groups (1) · Gonadotropin-Releasing Hormone (1) · Leuprolide (1) · Norethindrone Acetate (1)
Center for Vulvovaginal Disorders (1) · Dr. Santiago Palacios (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · Tehran University of Medical Sciences (1)
United States (2) · Iran (1) · Spain (1)